Narita M - Search Results

1

Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.

Reves R, Heilig CM, Tapy JM, Bozeman L, Kyle RP, Hamilton CD, Bock N, Narita M, Wing D, Hershfield E, Goldberg SV; Tuberculosis Trials Consortium. Reves R, et al. Among authors: narita m. Int J Tuberc Lung Dis. 2014 May;18(5):571-80. doi: 10.5588/ijtld.13.0304. Int J Tuberc Lung Dis. 2014. PMID: 24903795 Clinical Trial.

2

Outbreak of tuberculosis in a homeless population involving multiple sites of transmission.

Lofy KH, McElroy PD, Lake L, Cowan LS, Diem LA, Goldberg SV, Cangelosi GA, Tribble SP, Cave MD, Narita M. Lofy KH, et al. Among authors: narita m. Int J Tuberc Lung Dis. 2006 Jun;10(6):683-9. Int J Tuberc Lung Dis. 2006. PMID: 16776457

3

Impact of smear microscopy results and observed therapy on tuberculosis treatment in Mombasa, Kenya.

Arentz M, Narita M, Sangaré L, Kah JF, Low D, Mandaliya K, Amukoye E, Sitienei J, Walson JL. Arentz M, et al. Among authors: narita m. Int J Tuberc Lung Dis. 2011 Dec;15(12):1656-63. doi: 10.5588/ijtld.10.0625. Int J Tuberc Lung Dis. 2011. PMID: 22118174

4

Experience with rifabutin replacing rifampin in the treatment of tuberculosis.

Horne DJ, Spitters C, Narita M. Horne DJ, et al. Among authors: narita m. Int J Tuberc Lung Dis. 2011 Nov;15(11):1485-9, i. doi: 10.5588/ijtld.11.0068. Int J Tuberc Lung Dis. 2011. PMID: 22008761 Free PMC article.

5

Ofloxacin population pharmacokinetics in patients with tuberculosis.

Stambaugh JJ, Berning SE, Bulpitt AE, Hollender ES, Narita M, Ashkin D, Peloquin CA. Stambaugh JJ, et al. Among authors: narita m. Int J Tuberc Lung Dis. 2002 Jun;6(6):503-9. doi: 10.5588/09640569513011. Int J Tuberc Lung Dis. 2002. PMID: 12068983

6

Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis.

Migliori GB, Sotgiu G, Gandhi NR, Falzon D, DeRiemer K, Centis R, Hollm-Delgado MG, Palmero D, Pérez-Guzmán C, Vargas MH, D'Ambrosio L, Spanevello A, Bauer M, Chan ED, Schaaf HS, Keshavjee S, Holtz TH, Menzies D; “The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB”. Migliori GB, et al. Eur Respir J. 2013 Jul;42(1):169-179. doi: 10.1183/09031936.00136312. Epub 2012 Oct 11. Eur Respir J. 2013. PMID: 23060633 Free PMC article.

7

Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis.

Nahid P, Bliven EE, Kim EY, Mac Kenzie WR, Stout JE, Diem L, Johnson JL, Gagneux S, Hopewell PC, Kato-Maeda M; Tuberculosis Trials Consortium. Nahid P, et al. PLoS One. 2010 May 20;5(5):e10753. doi: 10.1371/journal.pone.0010753. PLoS One. 2010. PMID: 20505778 Free PMC article.

8

Multicenter study of QuantiFERON^®-TB Gold Plus in patients with active tuberculosis.

Horne DJ, Jones BE, Kamada A, Fukushima K, Winthrop KL, Siegel SAR, Kovacs A, Anthony P, Meekin KA, Bhat S, Kerndt P, Chang A, Koelle DM, Narita M. Horne DJ, et al. Among authors: narita m. Int J Tuberc Lung Dis. 2018 Jun 1;22(6):617-621. doi: 10.5588/ijtld.17.0721. Int J Tuberc Lung Dis. 2018. PMID: 29862944

9

Analysis of risk factors for tuberculous infection following exposure at a homeless shelter.

Munn MS, Duchin JS, Kay M, Pecha M, Thibault CS, Narita M. Munn MS, et al. Among authors: narita m. Int J Tuberc Lung Dis. 2015 May;19(5):570-5. doi: 10.5588/ijtld.14.0648. Int J Tuberc Lung Dis. 2015. PMID: 25868026

10

Pretomanid in the Treatment of Patients with Tuberculosis in the United States.

Goswami ND, Ashkin D, Haley CA; BAM Project Team. Goswami ND, et al. N Engl J Med. 2022 Sep 1;387(9):850-852. doi: 10.1056/NEJMc2119461. N Engl J Med. 2022. PMID: 36053513 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,729 results

Search Page